Abstract
Skin and soft tissue infections (SSTIs) are an important cause of morbidity and mortality in pregnant and postpartum women. SSTIs in pregnancy and puerperium range from mild to a moderate variety of infections like cellulitis, simple abscess, mastitis to severe degrees of fulminant infections like necrotizing fasciitis. Most SSTIs in puerperium originate at the breast, infected wound site following a surgical procedure, or traumatic vaginal deliveries. Mastitis and breast abscess represent an important category of SSTIs in the postpartum period associated with high morbidity; also affecting the neonatal well-being resulting from discontinuation of breastfeeding. SSTIs like necrotizing fasciitis are a rare but potential source of life-threatening complications in pregnant and postpartum women with high maternal mortality. Dominant organisms that are isolated in most cases of SSTIs are Gram-positive bacteria such as Staphylococcus aureus and Streptococcus; however, polymicrobial infections with Gram-negative and anaerobic organisms are not uncommon in severe infections. Uncomplicated SSTIs are successfully managed on an outpatient basis; severe infections extending to the deeper tissues—subcutaneous tissue, fascia, or muscle require aggressive management. Early diagnosis, the institution of appropriate antibiotics, and well-timed surgical management, if required, are key to the effective management of complicated SSTI to prevent maternal morbidity and mortality. Here, we review the etiopathology, clinical features, and treatment strategies for the management of SSTIs in pregnancy and the postpartum period.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Boakes E, Woods A, Johnson N, Kadoglou N. Breast infection: a review of diagnosis and management practices. Eur J Breast Health. 2018;14(3):136–43.
Lam E, Chan T, Wiseman SM. Breast abscess: evidence based management recommendations. Expert Rev Anti-Infect Ther. 2014;12(7):753–62.
Rizzo M, Gabram S, Staley C, Peng L, Frisch A, Jurado M, et al. Management of breast abscesses in nonlactating women. Am Surg. 2010;76(3):292–5.
Scott-Conner CE, Schorr SJ. The diagnosis and management of breast problems during pregnancy and lactation. Am J Surg. 1995;170(4):401–5.
Jahanfar S, Ng CJ, Teng CL. Antibiotics for mastitis in breastfeeding women. Cochrane Database Syst Rev. 2013;2:CD005458.
Amir LH. Academy of breastfeeding medicine protocol C. ABM clinical protocol #4: mastitis, revised March 2014. Breastfeed Med. 2014;9(5):239–43.
Bharat A, Gao F, Aft RL, Gillanders WE, Eberlein TJ, Margenthaler JA. Predictors of primary breast abscesses and recurrence. World J Surg. 2009;33(12):2582–6.
Givens ML, Luszczak M. Breast disorders: a review for emergency physicians. J Emerg Med. 2002;22(1):59–65.
Moazzez A, Kelso RL, Towfigh S, Sohn H, Berne TV, Mason RJ. Breast abscess bacteriologic features in the era of community-acquired methicillin-resistant Staphylococcus aureus epidemics. Arch Surg. 2007;142(9):881–4.
Jeng A, Beheshti M, Li J, Nathan R. The role of beta-hemolytic streptococci in causing diffuse, nonculturable cellulitis: a prospective investigation. Medicine (Baltimore). 2010;89(4):217–26.
Bhumbra NA, McCullough SG. Skin and subcutaneous infections. Prim Care. 2003;30(1):1–24.
Kihiczak GG, Schwartz RA, Kapila R. Necrotizing fasciitis: a deadly infection. J Eur Acad Dermatol Venereol. 2006;20(4):365–9.
Nissman KW, Nissman DB, Leighton BL, Varaday SS, Lockhart EM. Necrotizing fasciitis after cesarean delivery. Anesthesiology. 2011;115(6):1301.
Poehlmann S, Varaklis K. Necrotizing fasciitis after delayed secondary wound closure and cesarean delivery. Obstet Gynecol. 1997;90(4 Pt 2):704–5.
Goepfert AR, Guinn DA, Andrews WW, Hauth JC. Necrotizing fasciitis after cesarean delivery. Obstet Gynecol. 1997;89(3):409–12.
Gallup DG, Freedman MA, Meguiar RV, Freedman SN, Nolan TE. Necrotizing fasciitis in gynecologic and obstetric patients: a surgical emergency. Am J Obstet Gynecol. 2002;187(2):305–10. discussion 10-1
Misiakos EP, Bagias G, Patapis P, Sotiropoulos D, Kanavidis P, Machairas A. Current concepts in the management of necrotizing fasciitis. Front Surg. 2014;1:36.
Huang KF, Hung MH, Lin YS, Lu CL, Liu C, Chen CC, et al. Independent predictors of mortality for necrotizing fasciitis: a retrospective analysis in a single institution. J Trauma. 2011;71(2):467–73. discussion 73
Morgan MS. Diagnosis and management of necrotising fasciitis: a multiparametric approach. J Hosp Infect. 2010;75(4):249–57.
Rantala S, Vuopio-Varkila J, Vuento R, Huhtala H, Syrjanen J. Predictors of mortality in beta-hemolytic streptococcal bacteremia: a population-based study. J Infect. 2009;58(4):266–72.
Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (laboratory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004;32(7):1535–41.
Schorge JO, Granter SR, Lerner LH, Feldman S. Postpartum and vulvar necrotizing fasciitis. Early clinical diagnosis and histopathologic correlation. J Reprod Med. 1998;43(7):586–90.
Bilton BD, Zibari GB, McMillan RW, Aultman DF, Dunn G, McDonald JC. Aggressive surgical management of necrotizing fasciitis serves to decrease mortality: a retrospective study. Am Surg. 1998;64(5):397–400. discussion-1
Brown DR, Davis NL, Lepawsky M, Cunningham J, Kortbeek J. A multicenter review of the treatment of major truncal necrotizing infections with and without hyperbaric oxygen therapy. Am J Surg. 1994;167(5):485–9.
Hajhosseini B, Kuehlmann BA, Bonham CA, Kamperman KJ, Gurtner GC. Hyperbaric oxygen therapy: descriptive review of the technology and current application in chronic wounds. Plast Reconstr Surg Glob Open. 2020;8(9):e 3136.
Hedetoft M, Madsen MB, Madsen LB, Hyldegaard O. Incidence, comorbidity and mortality in patients with necrotising soft-tissue infections, 2005-2018: a Danish nationwide register-based cohort study. BMJ Open. 2020;10(10):e041302.
Levett D, Bennett MH, Millar I. Adjunctive hyperbaric oxygen for necrotizing fasciitis. Cochrane Database Syst Rev. 2015;1:CD007937.
Norrby-Teglund A, Kaul R, Low DE, McGeer A, Newton DW, Andersson J, et al. Plasma from patients with severe invasive group a streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. J Immunol. 1996;156(8):3057–64.
Kaul R, McGeer A, Norrby-Teglund A, Kotb M, Schwartz B, O'Rourke K, et al. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis. 1999;28(4):800–7.
Linner A, Darenberg J, Sjolin J, Henriques-Normark B, Norrby-Teglund A. Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study. Clin Infect Dis. 2014;59(6):851–7.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Choudhary, D., Garg, P.K. (2022). Skin and Soft Tissue Infections in Pregnancy. In: Mehta, S., Grover, A. (eds) Infections and Pregnancy. Springer, Singapore. https://doi.org/10.1007/978-981-16-7865-3_35
Download citation
DOI: https://doi.org/10.1007/978-981-16-7865-3_35
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-16-7864-6
Online ISBN: 978-981-16-7865-3
eBook Packages: MedicineMedicine (R0)